DuPont de Nemours (NYSE:DD) Sets New 1-Year High Following Analyst Upgrade

DuPont de Nemours, Inc. (NYSE:DDGet Free Report) shares reached a new 52-week high on Thursday after Citigroup raised their price target on the stock from $47.00 to $50.00. Citigroup currently has a buy rating on the stock. DuPont de Nemours traded as high as $44.62 and last traded at $44.5870, with a volume of 1294109 shares. The stock had previously closed at $43.38.

Several other equities research analysts have also recently issued reports on DD. Deutsche Bank Aktiengesellschaft cut their target price on DuPont de Nemours from $90.00 to $46.00 and set a “buy” rating for the company in a research note on Tuesday, November 25th. JPMorgan Chase & Co. raised their price objective on DuPont de Nemours from $48.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, January 16th. Wells Fargo & Company decreased their target price on shares of DuPont de Nemours from $100.00 to $50.00 and set an “overweight” rating on the stock in a research report on Friday, November 7th. Wall Street Zen raised shares of DuPont de Nemours to a “hold” rating in a research note on Saturday, January 10th. Finally, Mizuho upped their price objective on shares of DuPont de Nemours from $44.00 to $46.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. Ten investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, DuPont de Nemours has an average rating of “Moderate Buy” and an average target price of $45.99.

Read Our Latest Research Report on DuPont de Nemours

Insider Transactions at DuPont de Nemours

In other news, SVP Erik T. Hoover sold 6,005 shares of the company’s stock in a transaction dated Friday, November 28th. The stock was sold at an average price of $39.79, for a total transaction of $238,938.95. Following the completion of the transaction, the senior vice president directly owned 112,101 shares of the company’s stock, valued at approximately $4,460,498.79. This represents a 5.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Lori Koch sold 9,011 shares of the firm’s stock in a transaction dated Friday, November 28th. The stock was sold at an average price of $39.46, for a total value of $355,574.06. Following the sale, the chief executive officer directly owned 288,326 shares in the company, valued at $11,377,343.96. This trade represents a 3.03% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.61% of the stock is owned by insiders.

Institutional Investors Weigh In On DuPont de Nemours

Several hedge funds and other institutional investors have recently bought and sold shares of DD. Princeton Global Asset Management LLC grew its holdings in shares of DuPont de Nemours by 64.4% during the second quarter. Princeton Global Asset Management LLC now owns 365 shares of the basic materials company’s stock worth $25,000 after purchasing an additional 143 shares during the last quarter. Salomon & Ludwin LLC grew its stake in DuPont de Nemours by 186.5% during the 3rd quarter. Salomon & Ludwin LLC now owns 318 shares of the basic materials company’s stock worth $25,000 after buying an additional 207 shares during the last quarter. Palisade Asset Management LLC purchased a new position in DuPont de Nemours during the 3rd quarter worth approximately $26,000. Financial Life Planners acquired a new position in DuPont de Nemours during the third quarter worth approximately $27,000. Finally, Imprint Wealth LLC purchased a new stake in DuPont de Nemours in the third quarter valued at approximately $27,000. 73.96% of the stock is currently owned by institutional investors and hedge funds.

DuPont de Nemours Price Performance

The firm has a market capitalization of $18.34 billion, a price-to-earnings ratio of -23.79, a P/E/G ratio of 3.22 and a beta of 1.08. The company has a fifty day moving average price of $40.94 and a two-hundred day moving average price of $35.54. The company has a quick ratio of 1.63, a current ratio of 2.00 and a debt-to-equity ratio of 0.30.

DuPont de Nemours (NYSE:DDGet Free Report) last announced its earnings results on Thursday, November 6th. The basic materials company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.05. The business had revenue of $3.07 billion for the quarter, compared to analysts’ expectations of $3.12 billion. DuPont de Nemours had a negative net margin of 6.17% and a positive return on equity of 7.81%. The company’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.18 EPS. DuPont de Nemours has set its Q4 2025 guidance at 0.430-0.430 EPS. On average, equities research analysts expect that DuPont de Nemours, Inc. will post 4.38 EPS for the current fiscal year.

DuPont de Nemours Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 28th were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Friday, November 28th. DuPont de Nemours’s dividend payout ratio (DPR) is presently -43.48%.

DuPont de Nemours declared that its Board of Directors has authorized a stock repurchase plan on Thursday, November 6th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the basic materials company to purchase up to 12.2% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its stock is undervalued.

DuPont de Nemours Company Profile

(Get Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

See Also

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.